Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | +2.33% | +2.33% | +28.47% |
Sales 2022 | 2.38M 199M | Sales 2023 | - | Capitalization | 10.25M 854M |
---|---|---|---|---|---|
Net income 2022 | -50M -4.17B | Net income 2023 | -65M -5.42B | EV / Sales 2022 | 21.8 x |
Net cash position 2022 | 5.73M 478M | Net Debt 2023 | 13.17M 1.1B | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.14
x | P/E ratio 2023 |
-0.11
x | Employees | 26 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.82% |
Latest transcript on iBio, Inc.
1 day | +2.33% | ||
1 week | +2.33% | ||
Current month | -56.65% | ||
1 month | -47.62% | ||
3 months | +49.15% | ||
6 months | -69.71% | ||
Current year | +28.47% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Brenner
CEO | Chief Executive Officer | 54 | 18/21/18 |
Felipe Duran
DFI | Director of Finance/CFO | 45 | 01/21/01 |
Phan Dillon
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chip Clark
CHM | Chairman | 56 | 23/21/23 |
Linda Armstrong
BRD | Director/Board Member | 61 | 14/20/14 |
Gary Sender
BRD | Director/Board Member | 62 | 14/20/14 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.76 | +2.33% | 60,203 |
25/24/25 | 1.72 | -9.47% | 250,564 |
24/24/24 | 1.9 | 0.00% | 99,189 |
23/24/23 | 1.9 | +6.74% | 167,580 |
22/24/22 | 1.78 | +3.49% | 103,682 |
Delayed Quote Nyse, April 27, 2024 at 01:40 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+28.47% | 15.16M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- IBIO Stock